NCT06954935

Brief Summary

Laparoscopic cholecystectomy is one of the commonly used surgical treatment methods for gallbladder diseases. However, many patients experience significant nausea and vomiting after laparoscopic cholecystectomy. It is observed that approximately 20% to 30% of patients experience postoperative nausea and vomiting as the most common complaint after laparoscopic cholecystectomy. This study aims to investigate the effectiveness of periorbital massage in postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 23, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 2, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2025

Completed
Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

4 months

First QC Date

April 23, 2025

Last Update Submit

April 30, 2025

Conditions

Keywords

nauseavomingperiorbital massage

Outcome Measures

Primary Outcomes (3)

  • Apfel risk score

    : Apfel Risk Score is a simple scoring used to determine the risk status of patients for PONV. Apfel Risk Score questions four factors such as being female, not smoking, having a history of PONV/motion sickness and using postoperative opioids. Each factor is evaluated as 1 point. Apfel risk score varies between 0-4 and is classified as low, medium and high risk. Apfel Risk score 0-1 is evaluated as low risk, 2 as medium risk and 3-4 as high risk.

    It will be filled half an hour before you go down for surgery.

  • Numerical Scale of Nausea

    The numerical scale of nausea is a scale that starts with "0 (no nausea)" and ends with "10 (very severe nausea)" and is given a numerical value with 1 cm intervals. The numerical scale is one-dimensional and is mainly used to evaluate the severity of pain.

    0, 2, 6, 12 and 24 hours after surgery

  • Postoperative Nausea and Vomiting Impact Scale

    There are four options in the two-question scale, each with 0, 1, 2, or 3 points. The first question asks whether there is vomiting or retching, if any, and the frequency; the answers are "0" no, "1" once, "2" twice, "3" three times or more, with four options. The second question asks whether there is nausea (feeling of discomfort in the stomach and feeling like vomiting), if any, whether the feeling of nausea affects your ability to get out of bed, move around comfortably in bed, walk normally, or your daily life activities such as eating and drinking; the answers are "0" not very often, "1" sometimes, "2" often or often, and "3" always, with four options. The numerical values of the answers given to the first and second questions are added up and the result is found.

    0, 2, 6, 12 and 24 hours after surgery

Study Arms (2)

periorbital massage

EXPERIMENTAL

The severity of nausea and frequency of vomiting of patients will be analyzed at the 2nd, 4th, 6th, 8th, 12th and 24th hours after surgery. 15 minutes before these evaluations, an electronic eye massager (irest manufacturing company, China) will be applied to the patient's eyeball (according to the manufacturer's instructions) for 15 minutes. 15 minutes after the intervention, the severity of nausea and vomiting of patients will be evaluated using the nausea numerical scale and the vomiting incidence evaluation form.

Other: periorbital massage

control

NO INTERVENTION

The severity of nausea and frequency of vomiting of patients will be analyzed at 2, 4, 6, 8, 12 and 24 hours after surgery. Data collection intervals will be the same in both control and intervention groups.

Interventions

An electronic eye massager (irest manufacturing company, China) will be applied. The massager has a vibration function and massages with a warm air bag.

periorbital massage

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who have laparoscopic cholecystectomy surgery under general anesthesia,
  • Those between the ages of 18-70,
  • Those who do not have a psychiatric disease,
  • Those who understand what they read and volunteer patients,
  • Those who do not have a hearing or speech problem,

You may not qualify if:

  • Patients undergoing emergency surgery,
  • Patients with psychiatric disorders
  • Patients who have taken another antiemetic drug within 24 hours before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tuğba Albayram

Gaziantep, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

NauseaVomiting

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

April 23, 2025

First Posted

May 2, 2025

Study Start

April 23, 2025

Primary Completion

August 25, 2025

Study Completion

September 10, 2025

Last Updated

May 2, 2025

Record last verified: 2025-04

Locations